Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
PLoS One. 2012;7(9):e44586. doi: 10.1371/journal.pone.0044586. Epub 2012 Sep 5.
Decreased epinephrine (EPI) is an important underlying factor of bronchoconstriction in asthma. Exogenous β(2)-adrenergic receptor agonist is one of the preferred options to treat asthma. We previously showed that this phenomenon involved adrenal medullary chromaffin cell (AMCC) transformation to a neuron phenotype. However, the underlying molecular mechanism is not fully understood. To further explore this, an asthmatic model with unilateral adrenalectomy was established in this study.
METHODOLOGY/PRINCIPAL FINDINGS: Thirty-two rats were randomly into four groups (n = 8 each) control rats (controls), unilateral adrenalectomy rats (surgery-control, s-control), asthmatic rats (asthma), unilateral adrenalectomy asthmatic rats (surgery-induced asthma, s-asthma). Asthmatic rats and s-asthmatic rats were sensitized and challenged with ovalbumin (OVA). The pathological changes in adrenal medulla tissues were observed under microscopy. EPI and its rate-limiting enzyme, phenylethanolamine N-methyl transferase (PNMT), were measured. Peripherin, a type III intermediate filament protein, was also detected in each group. The asthmatic rats presented with decreased chromaffin granules and swollen mitochondria in AMCCs, and the s-asthmatic rats presented more serious pathological changes than those in asthmatic rats and s-control rats. The expressions of EPI and PNMT in asthmatic rats were significantly decreased, as compared with levels in controls (P<0.05), and a further decline was observed in s-asthmatic rats (P<0.05). The expression of peripherin was higher in the asthmatic rats than in the controls, and the highest level was found in the s-asthmatic rats (P<0.05).
CONCLUSION/SIGNIFICANCE: Compared with asthmatic rats and s-control rats, the transformation tendency of AMCCs to neurons is more obvious in the s-asthmatic rats. Moreover, this phenotype alteration in the asthmatic rats is accompanied by reduced EPI and PNMT, and increased peripherin expression. This result provides further evidence to support the notion that phenotype alteration of AMCCs contributes to asthma pathogenesis.
肾上腺素(EPI)减少是哮喘支气管收缩的一个重要潜在因素。外源性β(2)-肾上腺素能受体激动剂是治疗哮喘的首选方法之一。我们之前的研究表明,这种现象涉及肾上腺髓质嗜铬细胞(AMCC)向神经元表型的转化。然而,其潜在的分子机制尚不完全清楚。为了进一步探讨这一现象,本研究建立了单侧肾上腺切除术哮喘模型。
方法/主要发现:32 只大鼠随机分为 4 组(每组 8 只):对照组(对照组)、单侧肾上腺切除术大鼠(手术对照组,s-control)、哮喘大鼠(哮喘组)、单侧肾上腺切除术哮喘大鼠(手术诱导哮喘组,s-asthma)。哮喘大鼠和 s-asthma 大鼠用卵白蛋白(OVA)致敏和激发。显微镜下观察肾上腺髓质组织的病理变化。测量 EPI 及其限速酶苯乙醇胺 N-甲基转移酶(PNMT)。各组均检测外周蛋白,一种 III 型中间丝蛋白。哮喘大鼠 AMCC 中的嗜铬颗粒减少,线粒体肿胀,s-asthma 大鼠的病理变化比哮喘大鼠和 s-control 大鼠更严重。与对照组相比,哮喘大鼠 EPI 和 PNMT 的表达明显降低(P<0.05),s-asthma 大鼠的表达进一步降低(P<0.05)。与对照组相比,哮喘大鼠外周蛋白表达升高,s-asthma 大鼠表达最高(P<0.05)。
结论/意义:与哮喘大鼠和 s-control 大鼠相比,s-asthma 大鼠 AMCC 向神经元的转化趋势更为明显。此外,这种表型改变伴随着 EPI 和 PNMT 的减少,以及外周蛋白表达的增加。这一结果为支持 AMCC 表型改变导致哮喘发病机制的观点提供了进一步的证据。